Methods and materials for biosynthesis of mogroside compounds

US9932619B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9932619-B2
Application numberUS-201314442694-A
CountryUS
Kind codeB2
Filing dateDec 4, 2013
Priority dateDec 4, 2012
Publication dateApr 3, 2018
Grant dateApr 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to methods for producing mogrosides with the aid of enzymes. In particular the invention proposes various biosynthetic pathways useful for mogroside production and enzymes useful for mogroside production are provided. Furthermore, the invention provides recombinant hosts useful in performing the methods of the invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant host cell capable of producing a mogrol precursor, a mogroside precursor, and/or a mogroside compound in a cell culture, the recombinant host cell comprising: (a) a gene encoding a polypeptide capable of catalyzing conversion of oxido-squalene to produce cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 1; (b) a gene encoding a polypeptide capable of catalyzing conversion of dioxido-squalene to produce 24,25-epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 1; (c) a gene encoding a polypeptide capable of catalyzing hydroxylation of cucurbitadienol to produce 11-hydroxy-cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 3-20 or 41; (d) a gene encoding a polypeptide capable of catalyzing conversion of 11-hydroxy-cucurbitadienol to produce mogrol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 3-20 or 41; (e) a gene encoding a polypeptide capable of catalyzing epoxidation of 11-hydroxy-cucurbitadienol to produce 11-hydroxy-24,25-epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 3-20 or 41; (f) a gene encoding a polypeptide capable of catalyzing conversion of 11-hydroxy-24,25-epoxy cucurbitadienol to produce mogrol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 3-20 or 41; (g) a gene encoding a polypeptide capable of catalyzing epoxidation of cucurbitadienol to produce 24,25-epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 3-20 or 41; (h) a gene encoding a polypeptide capable of catalyzing hydroxylation of 24,25-epoxy cucurbitadienol to produce 11-hydroxy-24,25-epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 3-20 or 41; and/or (i) a gene encoding a polypeptide capable of catalyzing glycosylation of mogrol and/or glycosylated mogrol to produce a mogroside compound; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs: 21-25 and/or a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by the nucleotide sequence set forth in any one of SEQ ID NOs: 26-36; wherein at least one of the genes is a recombinant gene. 2. The recombinant host cell of claim 1 , comprising components (c), (d), and (i). 3. The recombinant host cell of claim 1 , comprising components (b), (f), (h), and (i). 4. The recombinant host cell of claim 1 , comprising components (f), (h), and (i). 5. The recombinant host cell of claim 1 , comprising component (i). 6. The recombinant host cell of claim 1 , wherein the recombinant host cell further comprises a heterologous nucleic acid encoding a squalene epoxidase (ERG1) polypeptide (ERG1) polypeptide. 7. The recombinant host cell of claim 1 , wherein the recombinant host cell has been modified to have reduced expression of a lanosterol synthase (ERG7) polypeptide (ERG7) polypeptide. 8. The recombinant host cell of claim 1 , wherein the recombinant host cell is a microorganism that is a plant cell, a mammalian cell, an insect cell, a fungal cell, an algal cell, or a bacterial cell. 9. The recombinant host cell of claim 8 , wherein the bacterial cell is an Escherichia, Lactobacillus, Lactococcus, Corynebacterium, Acetobacter, Acinetobacter , or Pseudomonas cell. 10. The recombinant host cell of claim 8 , wherein the fungal cell is a yeast cell. 11. The recombinant host cell of claim 10 , wherein the yeast cell is a Saccharomyces cerevisiae, Schizosaccharomyces pombe, Yarrowia lipolytica, Candida glabrata, Ashbya gossypii, Cyberlindnera jadinii, Pichia pastoris, Kluyveromyces lactis, Hansenula polymorpha, Candida boidinii, Arxula adeninivorans, Xanthophyllomyces dendrorhous , or Candida albicans cell. 12. The recombinant host cell of claim 11 , wherein the yeast cell is a Saccharomycete. 13. The recombinant host cell of claim 12 , wherein the yeast cell is a cell from the Saccharomyces cerevisiae species. 14. The recombinant host cell of claim 1 , comprising components (a), (c), (d) and (i). 15. The recombinant host cell of claim 1 , comprising components (a), (c), (e), (f), and (i). 16. The recombinant host cell of claim 1 , comprising components (a), (g), (h), (f), and (i). 17. The recombinant host cell of claim 1 , wherein the mogroside compound is glycosylated at its C-24 hydroxyl group; wherein the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs: 21-25 and/or a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by the nucleotide sequence set forth in any one of SEQ ID NOs: 26-36. 18. The recombinant host cell of claim 1 , wherein the mogroside compound is glycosylated at its C-3 hydroxyl group; wherein the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs: 21-25. 19. The recombinant host cell of claim 1 , wherein the mogroside compound is mogroside I A1, mogroside I E1, mogroside II A, mogroside II E, mogroside III, mogroside III A1, mogroside III A2, mogroside IV, siamenoside, or mogroside V. 20. The recombinant host cell of claim 1 , wherein the mogrol precursor is squalene, oxidosqualene, dioxidosqualene, cucurbitadienol, 24,25-epoxy cucurbitadienol, 11-hydroxy-cucurbitadienol, 11-hydroxy-24,25-epoxy cucurbitadienol, or 11-oxo-mogrol. 21. The recombinant host cell of claim 1 , wherein the recombinant host cell is a Yarrowia lipolytica cell. 22. The recombinant host cell of claim 1 , wherein: (a) the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 26-36 or the amino acid sequence set forth in any one of SEQ ID NOs: 21-25 and the mogroside compound is mogroside I A1; (b) the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs: 21-25 and the mogroside compound is mogroside I E1; (c) the glycosylation is effected by the activity of the polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in any one of SEQ ID NOs: 26-36 or the amino acid sequence set forth in any one of SEQ ID NOs: 21-25 and the mogroside compound

Assignees

Inventors

Classifications

  • Hydrolases (3) · CPC title

  • for fungi · CPC title

  • with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13 · CPC title

  • Isomerases (5.) · CPC title

  • at 11 position · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9932619B2 cover?
The invention relates to methods for producing mogrosides with the aid of enzymes. In particular the invention proposes various biosynthetic pathways useful for mogroside production and enzymes useful for mogroside production are provided. Furthermore, the invention provides recombinant hosts useful in performing the methods of the invention.
Who is the assignee on this patent?
Evolva Sa
What technology area does this patent fall under?
Primary CPC classification C12P33/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).